A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma
Clinical trial NCT05050097 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05050097
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-22
- Primary completion
- 2025-03-31
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.